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INTRODUCTION 
Secondary hyperparathyroidism is present in most patients with 
chronic renal failure (11. 20. 21). The effect of renal transplan-
tation on parathyroid function has been generally studied over 
a relatively short period of time after surgery (1. 6). Thus the 
information which could be obtained was insufficient to provide 
evidence regarding the long-term variations in the parathyroid 
activity in renal homograft recipients. Acute .hypercalcemia 
immediately after kidney transplantation has been reported in 
detail by several investigators (12. 11. 19). Parathyroidectomy 
which was the treatment of choice resulted in a prompt reduction 
of the high serum calcium concentrations and a relief. of the 
attendant clinical manifestations in the reported cases (12. 11. 19). 
The pathogenesis of acute post-transplant hypercalcemia has not 
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been fully defined, yet several contributing factors could be 
implicated: (1) the presence of high levels of parathyroid hormone 
with restored to normal bone responsiveness to the hormone, 
(2) fall in serum concentration of phosphorus with a reciprocal 
rise in serum calcium, and (3) correction of the abnormal meta-
bolism of Vitamin 0 with an enhanced conversion of the vitamin 
to its active metabolites. 
Several workers postulated that resolution of secondary hyper-
parathyroidism after kidney transplantation occurs almost uni-
versally whereas hypercalcemia is unfrequent and if present it is 
usually associated with phosphate depletion and can be easily 
controlled with phosphate supplementation (1, 6, 7). These 
considerations were consistent with the generally accepted 
concepts of non- autonomy of the parathyroid hyperfunction in 
chronic renal failure (21) which readily undergoes regression 
once normal horneostasis is· reestablished by the renal homo-
graft. However, these views, unfortunately, were not substan-
tiated by long-term observations. Serial measurements of para-
thyroid hormone levels in the serum of transplanted pati'9nts 
utilizing a radioimmunoassay yielded conflicting results and dis-
cordant conclusions (6, 17). More precise definition of the 
relation between the measured radioimmunoreactive substcmce 
and the circulating biologically active hormone seems important 
for more meaningful conclusions in the future studies. The size 
and the morphology of parathyroid glands in autopsy material 
from deceased homograft recipients has not been studied sys-
tematically yet; in fact, pathological observations led to the first 
recognition of secondary hyperparathyroidism in patients with 
chronic renal disease (14). 
Several factors which may affect parathyroid activity after kidney 
transplantation ar·e worth short comment. First recent studies 
demonstrated. that glucocorticoids by lowering serum calcium 
concentration cause an increase in the secretion of parathyroid 
hormone (23). Thus the use of glucocorticoids as immunosup-
pressive agents especially in high doses may suppress hypercal-
cemia and at the same time exert a stimulating effect on the para-
thyroid glands. Likewise the antagonism of glucocorticoids to 
the action of Vitarlin 0 (5, 2) may lead to a fall in serum calcium 
with further incfi3ase in parathyroid hyperactivity. Secondly, 
losses of phosphate after kidney transplantation caused by 
enhanced phosphaturia and antacids which bind phosphorus in 
the gut may result in hypophosphatemia (1). Hypophospha-
temia has been implicated as responsible for the appearanCb~ of 
hypercalcemia (1, 6, 7, 19). In fact the ensuing hypercalcemia 
is not necessarily an indication of additional stimulation of the 
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parathyroids but rather may reflect an increased skeletal response 
to parathyroid hormone. Conversely, supplementation of phos-
phate with a subsequent drop in serum calcium to normal or 
subnormal levels may actually become a stimulus for parathyroid 
hyperactivity (8, 9). Thirdly, thiazide diuretics have been 
shown to induce hypercalcemia under certain conditions (15). 
In dogs, thiazides have been reported to cauSe hyperplasia of 
the parathyroid glands (16), but their effect on human glands 
remains to be determined. The frequent use of thiazides in 
renal homograft recipients may playa definitive yet unknown 
role in parathyroid function. 
The present study which was undertaken to characterize the 
course of secondary hyperparathyroidism after kidney transplan-
tation suggests that persistent hyperparathyroidism may be 
detrimental to the function of renal homograft and therefore its 
prompt detection and treatment are of paramount importance. 
MATERIAL AND METHODS 
Eighteen renal homograft recipients with surgically proved para-
thyroid hypertrophy in which parathyroid hyperplasia was demon-
strated by microscopic examination serve as the basis for the 
present communications *. The clinical data of all patients are 
listed in table 1. All had chronic renal failure and all except for 
two were treated with hemodialysis before homotransplantation. 
Fourteen received renal homografts from related donors and 
4 from cadavers. The creatinine clearances after kidney trans-
plantation ranged from 46 to 95 with a mean value of 70 ml/mil'1. 
Four patients showed roentgenographic evidence of osteitis 
fibrosa cystica, 7 presented with calcium deposits in soft tissues 
and in the remainder varying degrees of skeletal rarefaction were 
noticed, before parathyroidectomy. The interval between trans-
plantation and parathyroidectomy ranged from 2 to 63 months 
with a mean duration of 22 months. Eight patients were sub-
jected to total parathyroidectomy with autoimplantation, the 
remainder underwent subtotal parathyroidectomy. The technique 
of the former surgical procedure is outlined in figure 1. This 
technique was designed to reduce the blood supply to the resi-
dual parathyroid tissue so as to minimize the risk of recurrent 
hypertrophy. Serum concentrations of phosphorus, total and 
ionic calcium were determined in all patients. Creatinine clear-
• These patients do not represent the Incidence of persistent hyperparathyroidism in our patient population 
but constitute a small portion of a large group of homograft recipients which are undergoing currently evaluation 
for parathyroidectomy 
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f~AoAqevolfa AUTOTRANSPLANT 
A 
PARATHYROID GLAND SECTIONBD 
TRANSFIXION OF SEGIIEIITS OF PARA-
THYROID GLAIID III'l'O POClCETS OF 
STERNOCLEIDOMlISTOID IIlSCLE USIlIG 
5- 0 WIRE SUruRE. 
Fig. 1.-Technique of parathyroid autotransplantation. A) A single gland is removed 
and sliced into two 50 mg segments. B) Each of two segments is inserted into a small 
pocket of sternocleidomaswid muscle and transfixed with 5-0 stainless steel wire. 
ances based on 24 hr urine collections were used as estimatl3s 
of glomerular filtration rate. Tubular reabsorption of phosphorus 
was calculated on the basis on 24 hourly excretions of phospho-
rus in the urine. The indication for surgery was persistently 
elevated serum concentration of ionized calcium with or without 
elevated above normal total serum calcium. The normal ran~le 
for total serum calcium in our laboratory as determined by atomic 
absorption spectrophotometry is 8.8 to 10.8 ml/100 ml whereas 
the normal range for ionized calcium as determined by Orion ion 
exchange electrode ranges from 4.0 to 4.9 mg!1 00 ml. 
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Fig. 2.-Peak serum levels of total and ionized calcium before parathyroidectomy. The 
hatched areas designate normal range for both total and ionized calcium. 
Patient Sex Age Diag-years nosis 
--- --- --- ---
PC M 41 CG 
SM F 22 PN 
HS M 21 MD 
CS F 10 CG 
CR F 39 CG 
MN F 43 CG 
SK M 27 CG 
WH M 30 CG 
PR M 17 CG 
KC F 13 HD 
SC , F 30 CG I 
WA M 48 CG 
DW F 32 CG 
WK M 11 CG 
BS M 39 CG 
PD F 24 CG 
SE F 40 PK 
JA F 39 LN 
Abbreviations: 
CG: 
PN: 
MD 
PK: 
LN: 
R: 
C 
chronic glomerulonephritis. 
chronic pyelonephritis. 
medullary cystic disease. 
polycystic kidneys. 
lupus nephropathy. 
related. 
cadaveric. 
RESULTS 
Table I 
Clinical data of all patients 
Dlaly- Donor SIS 
--- ---
Yes R 
Yes R 
Yes C 
Yes R 
Yes R 
Yes C 
Yes C 
Yes R 
Yes R 
Yes C 
Yes R 
Yes R 
Yes R 
No R 
Yes R 
Yes R 
Yes R 
No R 
C" PTX Bone Disease Extraskeletal 
ml/min Months osteop OFC calcifications 
------
------
95 2 + - Vascular 
70 7 - - -
81 14 + - -
55 18 + - Vascular 49 20 + - -90 32 + + Soft Tissue 54 47 + - ** Vascular 
Soft Tissue 
90 54 + - -
50 63 + - Vascular 
Soft Tissue 
51 53 + - -53 6 + + -
89 6 - + Vascular 64 18 +* - -
46 19 + + Soft Tissue 
74 39 + - -87 44 + - -75 2 + ** Vascular 
71 12 +* - -
PTX· time interval between transplantation 
and parathyroidectomy. 
OSTEOP: osteoporosis. 
OFC osteitis fibrosa cystica. 
aseptic necrosis of femoral heads. 
histological evidence of OFC. 
TOTAL AND IONIC SERUM CALCIUM CONCENTRATIONS 
Two patients with accelerated hypercalcemia and rapidly dete-
149 
tONZEO SERUM CAl.ClLM 
rng/lOOml 
8 
./ 
5 KDK~~KI-I-KDK:KK-------------
I ~K: •• " V . .. I· 
4 
10 
i 
I 
II 
,-0.51 
12 
TOTAL SERUM CALClJM 
me/lOOml 
P '0.001 
13 14 
Fig. 3.-The relationship between total and ionized serum calcium concentrations. The 
data represent all preoperative available determinations in all patients The broken 
vertical and horizontallires denote the maximal normal values for total and ionized caicium 
respectively. . 
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riorating renal function were operated 2 months after transplan-
tation; the remaining 16 were observed for longer periods of 
time and most were treated with phosphate supplements The 
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maximal serum concentrations of total and ionized calcium 
before parathyroidectomy are shown in figure 2. Seven of 
18 patients presented with total calcium within normal range 
whereas in all ionized calcium concentration was elevated above 
normal. Figure 3 illustrates in more detail the relationship 
between the total and the ionized serum calcium concentrations. 
The plotted data represent all preoperative determinations in all 
patients. There is a close direct relationship between both 
parameters. However, many determinations show high ionized 
calcium with normal total calcium concentration. 45.0 % of 
the plotted points fall in the upper left quadrant of the diagram 
showing high ionized serum calcium with normal total calcium 
concentration; only 35 % of all points are within the upper right 
quadrant indicating elevation of both serum calcium fractions. 
SERUM PHOSPHORUS AND TUBULAR REABSORPTION OF 
PHOSPHORUS 
Hypophosphatemia has been considered as a factor contributing 
to the appearance of hypercalcemia after kidney transplantation 
In primary hyperparathyroidism hypophosphatemia is due to a 
decreased tubular reabsorption of phosphorus and its correction 
with oral phosphate supplements may lower serum calcium 
concentration but the benefit accrued from chronic administration 
of phosphate salts is questionable (3). Figure 4 shows a direct 
relationship between serum concentration of phosphorus and 
fractional tubular reabsorption of phosphorus. The lowest serum 
concentrations are associated with the lowest tubular reabsorp-
tion of phosphorus, suggesting that excessive urinary losses are 
to a great extent responsible for the hypophosphatemia cur~ 
thermore, it appears that urinary losses are primarily due to high 
levels of circulating parathyroid hormone and not due to tubular 
defect in phosphorus reabsorption. The intactness of the trans-
planted nephrons with regard to phosphate reabsorption is 
shown in figure 5 which illustrates the changes in the fractional 
tubular reabsorption of phosphorus after total parathyroidectomy 
in 7 patients. The reabsorbed fraction reached 100 0/) despite 
the administration of thiazide diuretics and glucocorticoids which 
are known to have phosphaturic action. Inverse relationship 
between serum ionized calcium and tubular reabsorption of phos-
phorus is shown in figure 6. A marked scatter of the data is 
apparent and many points representing high ionized calcium 
correspond with a high fractional reabsorption of phosphorus 
even in excess of 80 %. In two patients TRP was consistently 
high before surgery. Thus normal TRP values did not preclude 
the presence of persistent hyperparathyroidism. 
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Fig. 5.-Serial determina-
tions of serum levels of cal-
cium and tubular reabsorp-
tion of phosphorus after 
total parathyroidectomy 
(PTX) with autotransplant. 
The broken line relates to 
a patient in whom the 
completeness of parathyroi-
dectomy was questionable. 
Hypophosphatemia was not consistently present in patients with 
hypercalcemia. Inverse relationship between serum phosphorus 
and ionized calcium levels is shown in figure 7. Although the 
highest levels of ionized calcium were associated with the lowest 
concentration of serum phosphorus. most of the data representing 
abnormally high concentration of ionized calcium fell within 
normal range for serum phosphorus (2.5 mg/100 ml and above). 
THE EFFECT OF ORAL PHOSPHATE SUPPLEMENTS ON 
TOTAL AND IONIC SERUM CALCIUM 
Figures 8. 9 and 10 illustrate sequential variations in total and 
ionized serum calcium levels in all patients with and without 
oral supplements of phosphate. 
Oral phosphate supplements were given either 3S potassiulTI 
phosphate (0.5-1.5 g elemental phosphorus per day) or as 
aluminum phosphate gel (Phosphaljel) 120 ml/day. In 6 patients 
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Fig. 6.-The relationship between ionized serum calcium and tubular reabsorption of 
phosphorus. The broken vertical line designates upper normal value for ionized calcium. 
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Fig. 7.-The relationship between serum phosphorus and ionized calcium. The horizontal 
broken line denotes upper normal value for ionized calcium. 
(fig. 8), the initially high serum calcium was reduced with 
phosphate supplements and remained within the normal range 
throughout the study till parathyroidectomy; however, the ionized 
calcium was persistently elevated. In 6 additional patients 
(fig. 9) elevated total serum calcium was reduced to normal with 
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Fig. B.-Serial variations in total and Ionized serum calcium in 6 patients showing a 
decrease in total calcium. Closed circles denote periods of phosphate supplementation 
and open circles periods without supplementation. Hatched areas denote normal range 
for total and ionized calcium. 
phosphate supplementation, however, recurrent hypercalcemia 
became apparent either when the patients were still on phosphate 
supplements or when those were discontinued. Ionized cal-
cium in most instances was elevated above normal. Another 
pattern of variations in serum calcium is shown in figure 10. In 
these patients (left column). total and ionic serum calcium failed 
to respond to phosphate supplementation and remained elevated. 
Additional 3 patients (right column) which were included in 
figure 10 were not treated with phosphate supplements. In the 
latter patients serum calcium fluctuated between normal and 
above normal range however ionized calcium was persistently 
elevated. 
THE EFFECT OF GLUCOCORTICOIDS ON SERUM CALCIUM 
CONCENTRATION 
Glucocorticoids have been used in treatment of hypercalcemia 
associated with conditions other than hyperparathyroidism, how-
ever reduction of calcium with glucocorticoids was also reported 
In primary hyperparathyroidism (4). Figure 11 shows the rela-
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Fig. g.-Serial changes in total and ionized calcium in 6 patients with late and recurrent 
hypercalcemia. Closed and open circles denote periods with and without phosphate 
supplementations respectively. Hatched areas denote normal range for total ionized 
calcium. 
tionship between the dose of prednisone and serum concen-
tration of total calcium before phosphate supplementation was 
started. In two patients (broken lines) the dose of glucocorti-
coids was tapered and discontinued abruptly because of a life 
threatening infection. Hypercalcemia ensued rapidly even though 
there was no change in serum phosphorus. In the other patients 
(solid lines) the dose of prednisone was decreased gradually 
after that stable homograft function was established. Lowering 
of the dose of prednisone was associated with a rise in serum 
calcium leading to the appearance of hypercalcemia. The varia-
ble time of onset of hypercalcemia in our patients could be partly 
due to the suppressive effect of glucocorticoids which also might 
be responsible for a continuous stimulation of the parathyroid 
glands (23, 22). 
THE EFFECT OF PARATHYROIDECTOMY ON RENAL 
FUNCTION 
Eleven of 15 patients (three patients had not sufficient data to 
be included) showed deterioration of kidney function prior to 
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Fig. 12.-Sequential variations in creatinine clearance in 4 patients who exhibited a 
decrease in renal function before parathyroidectomy (PTX) without change after surgery. 
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Fig. 1 3.-Serial determinations of creatinine clearance in 4 patients who maintained rela-
tively stable renal function. before and after parathyroidectomy (PTX). 
parathyroidectomy. Four patients with failing renal function 
(fig. 12) showed no noticeable change in creatinine Clearance 
after parathyroidectomy and so did four patients with stable 
renal function (fig. 13). Seven patients who exhibited pro-
gressive deterioration of kidney function prior to parathyroidec-
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Fig. 14.-Senal determinations of creatinine clearance in 7 patients who exhibited a 
deterioration in renal function with an improvement after parathyroidectomy (PTX). 
tomy exhibited a substantial increase in creatinine clearance after 
surgery (fig. 14). The degree of improvement seemed to be 
inversely related to the time interval between transplantation and 
parathyroidectomy. thus the sooner the parathyroidectomy was 
performed after transplantation the better was the improvement 
in kidney function. Figure 15 illustrates a typical clinical course 
as seen in one patient. 
In all patients there was a hypertrophy of the parathyroid glands. 
The weights rang l9d between 200 to 2.300 mg with a mean value 
of 875 mg. No correlation was found' between the parathyroid 
mass and the prEloperative level of ionized calcium and neither 
the duration of hypercalcemia. The drop in serum calcium 
concentrations and the increase in tubular reabsorption of phos-
phorus were more pronounced in patients undergoing total 
parathyroidectomv (fig. 5) than in those subjected to subtotal 
parathyroidectomv (fig. 16). 
CLINICAL MANIFESTATIONS 
The clinical manifestations related to hyperparathyroidism are 
presented in tab,le II. Three patients experienced bone pain 
which improved or resolved 2 to 4 months after parathyroidec-
tomy. Pain was related to aseptic necrosis of the hip in one 
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Fig. 15.-Typical course of variations in total and ionized serum calcium, serum phosphorus 
and creatinine clearance in patient H.S. after transplantation (TX). Appearance of 
hypercalcemia with decreasing the dose of prednisone. Initial response to oral phos-
phorus with a late failure resulting in recurrent hypercalcemia. Deterioration of renal 
function with marked improvement after parathyroidectomy (PTX). 
patient and to osteoporotic compression fractures of thoracic 
and lumbar vertebrae in one patient. Pain in the back muscles 
occured in one patient and resolved in one month. Generalized 
weakness was present in 8 patients. A dramatic improvement 
occured in all these patients from 1 to 4 months following para-
thyroidectomy. Severe recurrent headaches occured in two 
patients. Each of these had extensive neurological examinations 
and no etiology was obtained. One of these patients experienced 
immediate and permanent loss of headache symptoms following 
parathyroidectomy while the other had dramatic decline in the 
frequency and intensity of headaches. Four patients related 
profound improvement in facial hyperemia which occurred 
within the first two weeks after parathyroidectomy. 
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Fig. 16.-Serial changes i1 total and ionized serum calcium and tubular reabsorption 
of phosphorus after subtotal parathyroidectomy (PTX). Broken lines denote 2 patients 
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Table II 
Changes in clinical manifestations associated with parathyroidectomy. 
Patient Bone pain Muscle pain Weakness Headaches Facial Psychosis hyperemia 
P.c. - - Resolved - - -S.M. - - Resolved - - -
H.S - - Resolved - Improved Resolved 
C.S. - - - - - -
C.R. - - Improved - - -
MN Resolved Resolved - - - -
S.K. 
- - - - - -
WHo - - Resolved - - -
PR Resolved - Improved - - -
K.C 
- -
- Improved Improved -
S.Mc. - - - - - -
WA - - Improved - Improved -Ow. - - - - - -WK. - - - Resolved - -
BS - - - - - -
P.D - - Improved - Resolved -S.E. 
- - -
- -
-
JA Improved - - - - -
160 
DISCUSSION 
The present communication demonstrated that parathyroid hyper-
function may continue many years after kidney transplantation 
even in the presence of relatively adequate kidney function. The 
association of hyperparathyroidism with deteriorating kidney 
function, and moreover the improvement in creatinine clearance 
as noticed in our 7 patients after parathyroidectomy strongly 
suggests that persistent hyperparathyroidism may have a detri-
mental effect on the renal homograft. Although many factors 
other than secondary hyperparathyroidism could contribute to 
a decrease in renal function, hyperparathyroidism should always 
be considered as an important alternative. Furthermore, the 
beneficial effect of parathyroidectomy on renal function should 
not be underestimated especially when the relatively low opera-
tive risk of this procedure is considered. 
The importance of determining ionized calcium as a diagnostic 
aid is emphasized by our data. We have not found other cri-
teria as useful as this single determination. Similar observations 
regarding the diagnostic value of ionized calcium determinations 
were reported in patients with primary hyperparathyroidism (10). 
The factors responsible for persistent hyperparathyroidism after 
kidney transplantation are not well defined by the present study. 
Administration of phosphorus under various circumstances has 
been shown to be associated with parathyroid stimulation and 
occasionally with deterioration of renal function (13, 8, 9). 
Most of our patients were treated with phosphate supplements 
which by decreasing serbm calcium could be responsible for 
sustained stimulation of parathyroid function especially when 
given over long periods of time. 
The following observations regarding phosphate supplementa-
tion deserve emphasis: 1) phosphate supplementation may 
reduce total calcium concentration and in the absence of measured 
values of ionized calcium it may in fact mask the presence of 
hypercalcemia; 2) the suppression of total serum calcium may be 
temporary and a rebound may occur at unpredicted time. Fre-
quent determinations of total calcium may be necessary to ascer-
tain that hypercalcemia is recorded when it recurs. In addition 
ionized calcium may remain elevated despite normal total cal-
cium and 3) in certain patients hypercalcemia will resist phos-
phate supplementation. These findings question the usefulness 
of prolonged phosphate supplementation for post-transplant 
hypercalcemia. 
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Glucocorticoids may suppress hypercalcemia especially when 
given in large doses as demonstrated by the appearance of hyper-
calcemia in our patients as the dose of the steroids was reduced. 
The suppression of serum calcium may be a stimulus for conti-
nuous parathyroid hyperactivity. This possibility is supported 
by recently reported experimental data (23) which demonstra-
ted increased serum levels of immunoreactive parathyroid hor-
mone during the administration of glucocorticoids. In addition. 
the effect of glucocorticoids on Vitamin D metabolism (2) may 
be. an additional factor contributing to parathyroid hyperactivity. 
At last the degree of renal impairment as a cQuse of secondary 
hyperparathyroidism deserves a comment. The extent of the 
loss of renal function at which secondary hyperparathyroidism 
becomes apparent has not been established with certainty yet. 
however several investigators proposed that a relatively small 
decrease in renCiI function is sufficient to trigger parathyroid 
hyperactivity. Reiss et al. reported elevated levels of circulating 
radioimmunoreactive parathyroid hormone in patients with renal 
disease with cr€'atinine clearance of about 80 ml/min (18). 
Since many renal homografts seldom achieve 100 % of normal 
function and. in fact. in many creatinine clearance does not 
exceed 80 ml/min. it is not unlikely that the minimal to moderate 
decrease in kidney function plays a key role in maintaining hyper-
parathyroidism after transplantation. 
Supported by a grant (FR-51) from the General Clinical Resealch Centers Program 
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II. 
RELATION 
TO BONE DISEASE 
M.M. POPOVTZER, W.E. HUFFER, 
W.P. GElS, W.S. HAMMOND, 
T.E. STARZL 
INTRODUCTION 
It has been generally assumed that azotemic osteodystrophy 
resolves after kidney transplantation (3, 4). This notion was 
consistent with the proposed regression of secondary hyper-
parathyroidism after kidney transplantation (1, 3, 4) to which 
an important role was attributed in the pathogenesis of uremic 
bone disease. 
In spite of the apparent healing of azotemic osteodystrophy 
many recipients of renal homografts may suffer from various 
skeletal complications (2). The symptomatic bone disease is 
usually associated with varying degrees of radiographically 
demonstrable skeletal rarefaction. In addition spontaneous frac-
tures of different bones may occur, most frequently the affected 
bones are the hips, the feet and other weight-bearing parts 
of the skeleton. Avascular necrosis is another lesion frequently 
noticed in various bones. Occasionally it is difficult to diffe-
rentiate on the basis of roentenographic findings alone avascular 
necrosis from other destructive lesions of the bone such as 
osteomyelitis. These complications have been generally attri-
buted to immunosuppressive therapy with glucocorticoids. More-
over since no definitive treatment has been available for steroid 
induced osteoporosis only general supportive measures could 
be recommended. 
The present report is based on pathological findings pertinent 
to symptomatic bone disease in four renal homograft recipients. 
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Fig. 1.-Vertebral trabecular bone from patient A. Several osteoclasts are resorbing the 
left side of the trabecule. Decalcified paraffin embedded section, stained with hema-
toxYCIn and eosin. Original magnification 200 x. 
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Fig. 2.-Vertebral trabecular bone from patient B. Extensive osteoclastic resorption 
of external (lower left) and internal (center) portions of trabecules. There is no evidence 
of osteogenic activity or fibrOLIS replacement of the marrow. Tissue prepared as In figure 1. 
Original magnification. 200 x. 
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CASE REPORTS 
Patient A. This 30 year old male died of hepatitis 5 years after 
successful renal transplantation. During the last two years 
he experienced diffuse bone pains. Roentgenographic survey 
of the skeleton revealed generalized rarefaction, this finding 
was interpreted as steroid induced osteoporosis. Microscopic 
examination of the bones at autopsy disclosed severe resorptive 
bone disease with minimal amount of fibrous tissue and thin 
trabecules (fig. 1). 
Patient B. This 13 year old girl died four years after successful 
kidney transplantation of pneumonia. During the last two years, 
the patient complained of severe back pains and was found 
to have diffuse skeletal rarefaction which was interpreted as 
steroid induced osteoporosis. Microscopic examination of the 
bones at autopsy disclosed resorptive bone disease with poor 
fibrous tissue formation and thin trabecules (fig. 2). 
Patient C This 38 year old male died of encephalitis four years 
after successful renal transplantation Severe bone disease which 
affected both his upper and lower extremities prevented his 
rehabilitation and restricted him to a wheel chair. The roent-
genographic bone survey showed severe osteoporosis with des-
tructive lesions in the left talus (fig. 3) and the right humeral 
head (fig 4) which were interpreted as avascular necroses and 
Fig. PK~ The roentgenographic appearance of the left talus with the adjacent bones in 
patient C demonstrating avascular necrosIs. 
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Fig. 4.-The roentgeno9raphlc appearance of the right humeral head and the shoulder 
jOint in patient C. showing avascular necrosis. 
Fig. 5.-Vertebral trabecular bone from patient C. Extensive resorption has produced 
"railroad track" effect. The original trabecules are represented by thin bony walls 
enclosing a central marrow filled core. There is no evidence of an osteoeblastic or fibro-
blastic response. Tissue prepared and stained as in figure 1. Original magnification 
79 x. 
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were attributed to the steroid therapy At autopsy all 4 parathyroid 
glands were found to be enlarged and hyperplastic. The exa-
mination of the homograft revealed nephrocalcinosis The micro-
scopic examination of the bones revealed marked resorption with 
marked thinning of the trabecules and poor fibrous tissue for-
mation (fig. 5). 
Patient D. This 50 year old male died two years after kidney 
transplantation of systemic infection. During the last year, he 
had severe bone pains, sustained a spontaneous intertrochan-
teric fracture of the right upper hip which required pinning (fig. 6). 
Roentenographic bone survey revealed rarefaction which was 
interpreted as steroid induced osteoporosis. At autopsy all 
4 parathyroid glands were large and hyperplastic. The micro-
scopic examination of the bones revealed resorptive process 
with extremely thin trabecules and minimal fibrous tissue (fig. 7). 
Fig. 6.--The roentgenographic appearance of the right upper hip In patient D. showing 
rarefaction and Intertrochanteric fracture. 
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Fig. 7,-Vertebral trabecular bone from patient D, Osteoclastic resorption has produced 
changes similar to those described in the preceding illustration, Tissue prepared as in 
figure 1. Original magnification, 79 x. 
DISCUSSION 
The present report suggests that persistent parathyroid hyper-
function may be the underlying cause of disabling bone disease 
many years after successful kidney transplantation. The inability 
to establish the correct diagnosis during lifetime in the above 
4 patients could bel related to several factors. Firstly, the absence 
of characteristic roentgenographic findings of hyperparathyroidism 
such as resorption of cortical surfaces and the formation of 
cystic lesions. The roentgenographic feature of skeletal rare-
faction which was present in all 4 patients could reflect lack of 
new bone formation after that extensive resorption took place 
as indicated by the microscopic findings; this could be secondary 
to the effect of steroids on bone metabolism. Secondly. the 
absence of hypercalcemia typical of hyperparathyroidism was 
misleading. This could be partly due to suppression of serum 
calcium with glucocorticoids and/or inadequate number of deter-
minations of total and ionized calcium concentration in the serum. 
Thirdly. the lack of alertness to the possible presence of hyper-
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parathyroidism many years after transplantation and its role in 
the bone disease could be partly caused by the early reports pro-
posing resolution of secondary hyperparathyroidism after suc-
cessful kidney transplantation. However. in a recent study per-
sistently high levels of parathyroid hormone were found in patients 
with well-functioning renal homografts many years after trans-
plantation; furthermore a direct relationship was found between 
the level of radioimmunoreactive circulating hormone and the 
incidence of avascular necrosis (5). The latter and our findings 
taken together support the possible role of hyperparathyroidism 
in the pathogenesis of symptomatic bone disease after renal 
transplantation. In retrospect it seems that an earlier diagnosis 
of osteitis fibrosa cystica which could be made with a bone 
biopsy might have provided the clue to the therapy of the symp-
tomatic bone disease. It appears thus that the consideration 
of the diagnosis of persistent secondary hyperparathyroidism 
is imperative in patients with symptomatic bone disease after 
kidney transplantation. 
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